Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbott, Abbvie, academia, Academy, accrual, ActiveSight, ADA, adhere, Adjunct, advisor, African, agenda, Agouron, AI, Alberta, Alexander, Alfred, Alume, Amgen, Aon, array, artificial, Asian, aspire, Attn, Austin, autoimmune, automated, backbone, background, bacteria, banker, Barbara, batch, begun, Bellicum, biased, Bio, biochemistry, Biocom, biographical, biology, Biopharma, BIOSECURE, biosimilar, Black, blinded, book, Brainstorm, bylaw, CA, Cadence, Calgary, Canaccord, Canale, caption, car, carbon, carcinoma, career, CASL, Catherine, Celgene, CFR, chair, check, chemokine, chemoresistance, chosen, Chrysa, clawback, cofounder, cognizant, College, Collegium, colorectal, column, commensurate, comment, compatible, composed, compound, concept, concerted, conducive, contraindicated, contravention, coordinate, core, counsel, CRC, crucial, Cubist, cutlery, cytotoxic, Dartmouth, decommissioned, deep, deepen, deeper, delegate, delegated, dental, descent, diagnosed, Diploma, disability, dismemberment, disposition, disqualifying, Diversa, division, DNAX, Dr, Drake, Drinker, driver, Drs, Duke, Dura, efficient, Elan, Eli, Ernst, erroneously, escalate, escalating, ethical, ethnically, ethnicity, exceeded, excellence, excessive, excise, exemplified, expert, explicit, extracellular, faculty, Faegre, fake, Fellow, fellowship, female, FFS, fifty, fill, filled, Florida, footprint, forma, foundation, founder, Fuqua, gender, Genome, Genuity, Georgetown, Gilead, GP, graduate, grandfathered, green, half, Harvard, hearing, hedge, Heritage, highlighting, Hispanic, Hollaender, honest, honorific, house, Howard, Hygiene, Hyperion, ibrexafungerp, Ideaya, IDYA, immunologic, incentivize, Incline, incumbent, indemnify, Indiana, inherit, Inizio, inspired, installment, intelligence, Interagency, intersection, inventory, IRT, Jeff, John, joined, joining, Kaleido, Kauffman, Lampert, language, Latino, lawsuit, leaked, learning, leave, Leonard, Leslie, lessee, lieu, Lilly, link, LLP, lodging, logic, London, lump, machine, Mallinckrodt, Manitoba, master, mathematical, Matrix, McDaniel, membership, memory, Mineo, Mississippi, mix, ML, monotherapy, monumental, mount, Mpex, multiplying, multispecific, murine, Museum, Nabriva, naked, NASA, Naughton, NEO, Neurocrine, nominee, nonqualified, Nonstatutory, North, Novelli, NSCLC, NSO, NTAP, Oceanography, optionholder, OS, Otonomy, outlined, outlining, pancreatic, Paratek, parent, Path, Peel, peer, pembrolizumab, Pennsylvania, PEO, permissible, pertinent, Pharmacology, Pharmacopeial, philosophy, PIPEDA, polymerase, Porter, possessing, postdoctoral, PrEP, Princeton, prioritization, prioritize, pro, proactive, Professor, provincial, Pulmocide, pulmonary, qualitative, Quorex, race, racially, raw, reacquisition, reaction, reactivation, recoverability, recuse, Regeneron, reinvestment, Rempex, repricing, resignation, reusable, revealed, rigorously, rotation, Roth, Royal, Saisarva, salary, Sanofi, Santa, save, Schaeffer, Scholar, School, Scientist, Secretary, Senate, session, shape, shelf, shipment, Sidley, signaling, simultaneously, SIP, skilled, Sloan, slowdown, Sofinnova, son, sound, Southern, spheroid, split, spouse, Squibb, standing, Stanford, sterling, strike, Student, subscribe, subsidiary, subtraction, successor, sum, superseded, SV, symptomatic, Syrrx, tabletop, tactical, tailor, tailored, Tari, taxation, Therini, thought, transcriptase, transferee, translate, Treasurer, Tripex, triple, Tropical, Trustee, TSR, Tulsa, UCSD, unaudited, unexercised, unrest, unrestricted, unsaleable, unstable, unyielding, upcoming, URT, vacancy, vacation, vendor, venture, vi, vial, vice, Vir, visible, vision, Washington, Wednesday, Welfare, Wharton, wider, Wilcoxon, YourEncore, Zavante, Zoology
Removed:
acute, afflicted, allocable, AML, ASU, AUC, backstopped, bloodstream, BMT, bone, borrow, catheter, chance, Cmax, combine, comparator, compensating, compute, contact, Contemporaneously, crude, customary, customized, deadline, deadly, declare, define, developmental, dictated, die, disrupted, element, eliminating, embedded, emergency, entry, EPS, evolve, exemption, existed, extending, feature, fulfil, gastrointestinal, glabrata, Graft, heightening, hematologic, hematology, HIV, hospitalization, hospitalized, IDSA, immunosuppression, implied, infusion, inhibitory, innovative, interrupt, intrusion, Journal, leader, lend, leukemia, max, MIC, minimize, MRSA, necessitated, nephrotoxicity, nosocomial, numerically, nutrition, obese, oral, organ, outbreak, parenteral, pledge, poor, positioned, precautionary, prepay, prepayment, proliferate, random, randomization, recourse, reflective, remotely, removing, reset, restrictive, retrospective, RSV, run, safely, sequester, sought, spread, stem, stimulated, Stonepine, subscription, suggest, suppression, surgery, talented, tolerated, transform, transport, unlimited, unnecessary, vascular, Watch, widespread, worsen
Filing tables
Filing exhibits
- 10-K Annual report
- 3.2 Certificate of Amendment to Amended and Restated Certificate of Incorporation
- 10.5 Amended and Restated Non-employee Director Compensation Policy
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Securities Exchange Act of 1934
- 31.2 Certification of CFO Pursuant to Securities Exchange Act of 1934
- 32.1 Certification of CEO Pursuant to Sarbanes-oxley Act of 2002
- 32.2 Certification of CFO Pursuant to Sarbanes-oxley Act of 2002
- 97.1 Incentive Compensation Recoupment Policy
- Download Excel data file
- View Excel data file
CDTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-3 No. 333-260970) of Cidara Therapeutics, Inc., and
(2)Registration Statements (Form S-8 Nos. 333-203434, 333-210263, 333-216722, 333-228282, 333-231326, 333-236874, 333-253545, 333-259219, 333-263350 and 333-270781) pertaining to the Cidara Therapeutics, Inc. 2013 Stock Option and Grant Plan, Cidara Therapeutics, Inc. 2015 Equity Incentive Plan, Cidara Therapeutics, Inc. 2015 Employee Stock Purchase Plan and Cidara Therapeutics, Inc. 2020 Inducement Incentive Plan;
of our report dated April 22, 2024, with respect to the consolidated financial statements of Cidara Therapeutics, Inc. included in this Annual Report (Form 10-K) of Cidara Therapeutics, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
San Diego, California
April 22, 2024